Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 415
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03784755 | Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer | ||
| NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | ||
| NCT02758197 | Online MBSR Program for Cancer Survivors With Chronic Neuropathic Pain | ||
| NCT03271892 | Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer | ||
| NCT05451004 | SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer | ||
| NCT00282035 | RAPID: Randomized Trial of Accelerated Partial Breast Irradiation | ||
| NCT00343408 | AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer | ||
| NCT00658593 | Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | ||
| NCT01354171 | Active Surveillance Magnetic Resonance Imaging Study | ||
| NCT04650581 | Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor | ||
| NCT07297667 | GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours | ||
| NCT02788773 | Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT00002561 | Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease | ||
| NCT00040183 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. | ||
| NCT00003890 | MG98 in Treating Patients With Advanced Solid Tumors | ||
| NCT05754840 | CANnabinoids in Pediatric ONCology | ||
| NCT00499174 | Observation or Radical Treatment in Patients With Prostate Cancer | ||
| NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | ||
| NCT02597062 | High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma | ||
| NCT04918186 | Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer | ||
| NCT03266900 | A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival | ||
| NCT00003032 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer | ||
| NCT06641791 | Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer | ||
| NCT00303160 | Effect of Helicobacter Pylori on the Availability of Vitamin E and C | ||
| NCT00150917 | RCT of a Group Intervention for Women With a Family History of Breast Cancer | ||
| NCT01152788 | Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma | ||
| NCT00504296 | SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT00820248 | Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer | ||
| NCT03450018 | A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX | ||
| NCT07341191 | Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy | ||
| NCT04224974 | Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia | ||
| NCT03550391 | Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases | ||
| NCT01901094 | Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy | ||
| NCT02879318 | Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma | ||
| NCT06630273 | Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics | ||
| NCT02861703 | Pilot Feasibility Study of an Online Lifestyle Intervention for Overweight Breast Cancer Survivors | ||
| NCT00006036 | Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | ||
| NCT00066586 | Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer | ||
| NCT00064194 | Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia | ||
| NCT02272712 | The Effectiveness of Online Treatment for Insomnia in Cancer Survivors | ||
| NCT04746859 | Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program | ||
| NCT06043427 | Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma | ||
| NCT07152821 | Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma | ||
| NCT00156130 | Accelerated Radiotherapy Outcomes in Women | ||
| NCT00002864 | Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | ||
| NCT03629509 | BEFORE Decision Aid Implementation Study | ||
| NCT00869752 | MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | ||
| NCT03233711 | Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer | ||
| NCT02630693 | Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer | ||
| NCT03297606 | Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) |
